MacroGenics
Utility Patent Applications

Last updated:

List of all MacroGenics patents 38 in total

Status Patent
Application
Utility: Dosing Regimens of Bispecific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: Combination Therapy for the Treatment of Cancer External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: Pharmaceutical Compositions of a HER2/neu Antibody and Use of the Same External link
Filling date: 8 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: FcgammaRIIB-Specific Antibodies and Methods of Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: HER2/neu-Specific Antibodies and Methods of Using Same External link
Filling date: 8 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3 External link
Filling date: 8 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: Combination Therapy for the Treatment of Cancer External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 16 Dec 2021
Application
Utility: Optimized gp41-Binding Molecules and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 12 Aug 2021
Application
Utility: LAG-3-Binding Molecules and Methods of Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: NOVEL B7-H3 BINDING MOLECULES, ANTIBODY DRUG CONJUGATES THEREOF AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: Bispecific CD16-Binding Molecules and Their Use in the Treatment of Disease External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of Disease External link
Filling date: 8 Sep 2025 Issue date: 27 May 2021
Application
Utility: METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH PD-1 AND CTLA-4 External link
Filling date: 8 Sep 2025 Issue date: 6 May 2021
Application
Utility: COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: Dosing Regiments of Bi-Specific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies External link
Filling date: 8 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2021
Application
Utility: Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 18 Feb 2021
Application
Utility: Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting External link
Filling date: 8 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: BISPECIFIC MOLECULES COMPRISING AN HIV-1 ENVELOPE TARGETING ARM External link
Filling date: 8 Sep 2025 Issue date: 12 Nov 2020
Application
Utility: COMBINATION THERAPY External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 9 Jul 2020
Application
Utility: MULTI-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS External link
Filling date: 8 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: FcgammaRIIB-Specific Antibodies and Methods of Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 30 Apr 2020
Application
Utility: Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life External link
Filling date: 8 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND TUMOR ANTIGENS, AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: Combination Therapy for the Treatment of Cancer External link
Filling date: 8 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: ADAM9-Binding Molecules, and Methods of Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: Methods for the Use of CD32B x CD79B-Binding Molecules in the Treatment of Inflammatory Diseases and Disorders External link
Filling date: 8 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD32B and CD79b and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: HER2/neu-Specific Antibodies and Methods of Using Same External link
Filling date: 8 Sep 2025 Issue date: 1 Aug 2019

Showing 1 to 38 of 38 patents.